Evidence for an association between an enhanced reactivity of interleukin-6 levels and reduced glucocorticoid sensitivity in patients with fibromyalgia

Psychoneuroendocrinology

Volumn 37, Issue 5, 2012, Pages 671-684

  Geiss, Andrea ^a,b   Rohleder, Nicolas ^c   Anton, Fernand ^a,d  

^a UNIVERSITY OF TRIER   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c BRANDEIS UNIVERSITY   (United States)

^d UNIVERSITY OF LUXEMBOURG   (Luxembourg)

Author keywords

Chronic stress; Cortisol; Fatigue; Fibromyalgia syndrome; Glucocorticoid sensitivity; Hypothalamus pituitary adrenal axis; Interleukin 6; Pain; Pressure pain thresholds; Tumor necrosis factor

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID RECEPTOR; HYDROCORTISONE; INTERLEUKIN 6;

ADULT; AROUSAL; ARTICLE; BEHAVIORAL SCIENCE; BLOOD ANALYSIS; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DEXAMETHASONE SUPPRESSION TEST; DISEASE SEVERITY; FATIGUE; FEMALE; FIBROMYALGIA; HORMONE ACTION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; PAIN ASSESSMENT; PAIN THRESHOLD; PRIORITY JOURNAL; PROTEIN FUNCTION; SALIVA LEVEL; SYMPTOMATOLOGY; VISUAL ANALOG SCALE;

ADRENOCORTICOTROPIC HORMONE; ADULT; CIRCADIAN RHYTHM; DEXAMETHASONE; FATIGUE; FEMALE; FIBROMYALGIA; GLUCOCORTICOIDS; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INTERLEUKIN-6; MIDDLE AGED; PAIN MEASUREMENT; PAIN THRESHOLD; PITUITARY-ADRENAL SYSTEM; SALIVA;

EID: 84858451511     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2011.07.021     Document Type: Article

References (76)

1. Ahles T.A., Yunus M.B., Masi A.T. Is chronic pain a variant of depressive disease? The case of primary fibromyalgia syndrome. Pain 1987, 29:105-111.
2. Bazzichi G., Giannaccini G., Betti L., Italiani P., Fabbrini L., DeFeo F., Giacomelli C., Giuliano T., Rossi A., Uccelli A., Giusti L., Mascia G., Lucaacchini A., Bombardieri S. Peripheral benzodiazepine receptors on platelets of fibromyalgia patients. Clin. Biochem. 2006, 39:867-872.
3. Bornstein S.R., Chrousos G.P. Adrenocorticotropin (ACTH)- and non-ACTH-mediated regulation of the adrenal cortex: neural and immune inputs. J. Clin. Endocrinol. Metab. 1999, 84:1729-1736.
4. Bornstein S.R., Engeland W.C., Ehrhart-Bornstein M., Herman J.P. Dissociation of ACTH and glucocorticoids. Trends Endocrinol. Metab. 2008, 19:175-180.
5. Catley D., Kaell A.T., Kirschbaum C., Stone A.A. A naturalistic evaluation of cortisol secretion in persons with fibromyalgia and rheumatoid arthritis. Arthritis Care Res. 2000, 13:51-61.
6. Clark A.R. Anti-inflammatory functions of glucocorticoid-induced genes. Mol. Cell. Endocrinol. 2007, 275(7):9-97.
7. Cohen J. Statistical power analysis for the behavioral sciences 1987, Erlbaum, Hillsdale.
8. De Bosscher K., Haegeman G. Minireview: latest perspectives on antiinflammatory actions of glucocorticoids. Mol. Endocrinol. 2009, 23:281-291.
9. DeRijk R.H., Petrides J., Deuster P., Gold P.W., Sternberg E.M. Changes in corticosteroid sensitivity of peripheral blood lymphocytes after strenuous exercise in humans. J. Clin. Endocrinol. Metab. 1996, 81:228-235.
10. Dressendörfer R.A., Kirschbaum C., Rohde W., et al. Synthesis of a cortisol-biotin conjugate and evaluation as tracer in an immunoassay for salivary cortisol measurement. J. Steroid Biochem. Mol. Biol. 1992, 43:683-692.
11. Eddleston J., Herschbach J., Wagelie-Steffen A.L., Christiansen S.C., Zuraw B.L. The anti-inflammatory effect of glucocorticoids is mediated by glucocorticoid-induced leucine zipper in epithelial cells. J. Allergy Clin. Immunol. 2007, 119:115-122.
12. Edwards V.J., Holden G.W., Felitti V.J., Anda R.F. Relationship between multiple forms of childhood maltreatment and adult mental health in community respondents: results from the adverse childhood experiences study. Am. J. Psychiatry 2003, 160:1453-1460.
13. Edwards R.R., Kronfli T., Haythornthwaite J.A., Smith M.T., McGuire L., Page G.G. Association of catastrophizing with interleukin-6 response to acute pain. Pain 2008, 140:135-144.
14. Ehrhardt-Bornstein M., Hinson J.P., Bornstein S.R., et al. Intraadrenal interactions in the regulation of adrenocortical steroidgenesis. Endocr. Rev. 1998, 19:101-143.
15. Ferraccioli G., Cavalieri F., Salaffi F., Fontana S., Scita F., Nolli M., Maestri D. Neuroendocrinologic findings in primary fibromyalgia (soft tissue chronic pain syndrome) and in other chronic rheumatic conditions (rheumatoid arthritis, low back pain). J. Rheumatol. 1990, 17:869-873.
16. Fries E., Hesse J., Hellhammer J., Hellhammer D.H. A new view on hypocortisolism. Psychoneuroendocrinology 2005, 30:1010-1016.
17. Gaab J., Hüster D., Peisen R., Engert V., Heitz V., Schad T., Schürmeyer T.H., Ehlert U. Hypothalamic-pituitary-adrenal axis reactivity in chronic fatigue syndrome and health under psychological, physiological, and pharmacological stimulation. Psychosom. Med. 2002, 64:951-962.
18. Gaab J., Hüster D., Peisen R., Engert V., Schad T., Schürmeyer T.H., Ehlert U. Low-dose dexamethasone suppression test in chronic fatigue syndrome and health. Psychosom. Med. 2002, 64:311-318.
19. Geiss A., Rohleder N., Kirschbaum C., Steinbach K., Bauer H.W., Anton F. Predicting the failure of disc surgery by a hypofunctional HPA axis: evidence from a prospective study on patients undergoing disc surgery. Pain 2005, 114:104-117.
20. Geissner E. The Pain Perception Scale-a differentiated and change-sensitive scale for assessing chronic and acute pain. Rehabilitation 1995, 34:XXXV-XLIII.
21. Giske L., Vollestad N.K., Mengshoel A.M., Jensen J., Knardahl S., Roe C. Attenuated adrenergic responses to exercise in women with fibromyalgia-a controlled study. Eur. J. Pain 2008, 12:351-360.
22. Gillespie C.F., Nemeroff C.B. Hypercortisolemia and depression. Psychosom. Med. 2005, 67(Supplement 1):S26-S28.
23. Griep E.N., Boersma J.W., Lentjes E.G., Prins A.P., van der Korst J.K., de Kloet E.R. Function of the hypothalamic-pituitary-adrenal axis in patients with fibromyalgia and low back pain. J. Rheumatol. 1998, 25:1374-1381.
24. Gür A., Karakoc M., Nas K., Cevik R., Denli A., Sarac J. Cytokines and depression in cases with fibromyalgia. J. Rheumatol. 2002, 29:358-361.
25. Hautzinger M., Bailer M. Allgemeine Depressions Skala (ADS) 1993, Beltz, Weinheim.
26. Hays W.L. Statistics 1981, Holt Rinehart and Winston, New York.
27. Imbierowicz K., Egle U.T. Childhood adversities in patients with fibromyalgia and somatoform pain disorder. Eur. J. Pain 2003, 7:113-119.
28. Kadetoff D., Kosek E. Evidence of reduced sympatho-adrenal and hypothalamic-pituitary activity during static muscular work in patients with fibromyalgia. J. Rehabil. Med. 2010, 42:765-772.
29. Kavelaars A., Broeke D., Jeurissen F., Kardux J., Meijer A., Franklin R., Gelfand E.W., Heijnen C. Activation of human monocytes via a non-neurokinin substance P receptor that is coupled to Gi protein, calcium, phosphipase D, MAP kinase, and IL-6 production. J. Immunol. 1994, 153:3691-3699.
30. Keane T.M., Marshall A.D., Taft C.T. Posttraumatic stress disorder: etiology, epidemiology, and treatment outcome. Annu. Rev. Clin. Psychol. 2006, 2:161-197.
31. Kirschbaum C., Pirke K.M., Hellhammer D.H. The 'Trier Social Stress Test'-a tool for investigating psychobiological stress response in a laboratory setting. Neuropsychobiology 1993, 28:76-81.
32. Kivimäki M., Leino-Arjas P., Virtanen M., Elovainio M., Keltikangas-Järvinen L., Puttonen S., Vartia M., Brunner E., Vahtera J. Work stress and incidence of newly diagnosed fibromyalgia: prospective cohort study. J. Psychosom. Res. 2004, 57:417-422.
33. Klingmann P.O., Kugler I., Steffke T.S., Bellingrath S., Kudielka B.M., Hellhammer D.H. Sex-specific prenatal programming: a risk for fibromyalgia?. Ann. N.Y. Acad. Sci. 2008, 1148:446-455.
34. Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001, 16:606-613.
35. Kroenke K., Spitzer R.L., Williams J.B.W. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom. Med. 2002, 64:258-266.
36. Lahiri T., Laporte J.D., Moore P.E., Panettieri R.A., Shore S.A. Interleukin-6 family cytokines: signaling and effects in human airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 2001, L1225-L1232.
37. Lentjes E.G.W.M., Griep E.N., Boersma J.W., Romijn F.P.T.H.M., deKloet E.R. Glucocorticoid receptors, fibromyalgia and low back pain. Psychoneuroendocrinology 1997, 22:603-614.
38. Lieb K., Rexhausen J.E., Kahl K.G., Schweiger U., Philipsen A., Hellhammer D.H., Bohus M. Increased diurnal salivary cortisol in women with borderline personality disorder. J. Psychiatr. Res. 2004, 38:559-565.
39. Liu H., Liu K., Bodenner D.L. Estrogen receptor inhibits interleukin-6 gene expression by disruption of nuclear factor κB transactivation. Cytokine 2005, 31:251-257.
40. Loram L.C., Fuller A., Fick L.G., Cartmell T., Poole S., Mitchell D. Cytokine profiles during carrageenan-induced inflammatory hyperalgesia in rat muscle and hind paw. J. Pain 2007, 8:127-136.
41. Löwe B., Spitzer R.L., Zipfel S., Herzog W. Gesundheitsfragebogen für Patienten (PHQ-D). 2. Auflage 2002, Pfizer GmbH, Karlsruhe.
42. Lowy M.T., Meltzer H.Y. Dexamethasone bioavailability: implications for DST research. Biol. Psychiatry 1987, 22:373-385.
43. Macedo J.A., Hesse J., Turner J.D., Meyer J., Hellhammer D.H., Muller C.P. Glucocorticoid sensitivity in fibromyalgia patients: decreased expression of corticosteroid receptors and glucocorticoid-induced leucine zipper. Psychoneuroendocrinology 2008, 33:799-809.
44. Magni G., Moreschi C., Rigatti-Luchini S., Merskey H. Prospective study on the relationship between depressive symptoms and chronic musculoskeletal pain. Pain 1994, 56:289-297.
45. Mense S. The pathogenesis of muscle pain. Curr. Pain Headache Rep. 2003, 7:419-425.
46. Miller A.H., Maletic V., Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 2009, 65:732-741.
47. Nussdorfer G. Paracrine control of adrenal cortical function by medullary chromaffin cell. Pharmacol. Rev. 1996, 48:495-530.
48. Okugawa G., Omori K., Suzukawa J., Fujiseki Y., Kinoshita T., Inagaki C. Long-term treatment with antidepressants increases glucocorticoid receptor binding and gene expression in cultured rat hippocampal neurons. J. Neuroendocrinol. 1999, 11:887-895.
49. Ostrowski K., Hermann C., Bangash A., Schjerling P., Nielsen J.N., Pedersen B.K. A trauma-like elevation of plasma cytokines in humans in response to treadmill running. J. Physiol. 1998, 513:889-894.
50. Pascualy M., Petrie E.C., Brodkin K., Peskind E.R., Wilkinson C.W., Raskind M.A. Hypothalamic-pituitary-adrenocortical and sympathetic nervous system responses to the cold pressor test in Alzheimer's Disease. Biol. Psychiatry 2000, 48:247-254.
51. Pruessner J.C., Kirschbaum C., Meinlschmid G., Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 2003, 28:916-931.
52. Rohleder N., Wolf J.M., Wolf O.T. Glucocorticoid sensitivity of cognitive and inflammatory processes in depression and posttraumatic stress disorder. Neurosci. Biobehav. Rev. 2010, 35:104-114.
53. Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr. Rev. 1990, 11:80-91.
54. Sapolsky R.M., Romero L.M., Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr. Rev. 2000, 21:55-89.
55. Schratzberger P., Reinisch N., Prodinger W.M., Kähler C.M., Sitte B.A., Bellmann R., Fischer-Colbrie R., Winkler H., Wiedermann C.J. Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. J. Immunol. 1997, 158:3895-3901.
56. Schulz P., Schlotz W. Trierer Inventar zur Erfassung von chronischem Stress (TICS) Skalenkonstruktion, teststatistische überprüfung und Validierung der Skala Arbeitsüberlastung. Diagnostika 1999, 45:8-19.
57. Smedes F., Kraak J.C., Poppe H. Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine for plasma and urine. J. Chromatogr. 1982, 231:25-39.
58. Spitzer R.L., Kroenke K., Williams J.B.W. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 1999, 282:1737-1744.
59. Tanriverdi F., Karaca Z., Unluhizarci K., Kelestimur F. The hypothalamic-pituitary-adrenal axis in chronic fatigue syndrome and fibromyalgia syndrome. Stress 2007, 10:13-25.
60. Turk D.C., Okifuji A. Detecting depression in chronic pain patients: adequacy of self-reports. Behav. Res. Ther. 1994, 32:9-16.
61. Vedder H., Bening-Abu-Shach U., Lanquillon S., Krieg J.C. Regulation of glucocorticoid receptor-mRNA in human blood cells by amitriptyline and dexamethasone. J. Psychiatr. Res. 1999, 33:303-308.
62. Von Känel R., Kudielka B.M., Preckel D., Hanebuth D., Fischer J.E. Delayed response and lack of habituation in plasma interleukin-6 to acute mental stress in men. Brain Behav. Immun. 2006, 20:40-48.
63. Wallace D.J., Linker-Israeli M., Hallegua D., Silverman S., Siver D., Weisman M.H. Cytokines play an aetiopathogenetic role in fibromyalgia: a hypothesis and pilot study. Rheumatology 2001, 40:743-749.
64. Wang H., Moser M., Schiltenwolf M., Buchner M. Circulating cytokine levels compared to pain in patients with fibromyalgia-a prospective longitudinal study over 6 months. J. Rheumatol. 2008, 35:1366-1370.
65. Weissbecker I., Floyd A., Dedert E., Salmon P., Sephton S. Childhood trauma and diurnal cortisol disruption in fibromyalgia syndrome. Psychoneuroendocrinology 2006, 31:312-324.
66. Wingenfeld K., Wagner D., Schmidt I., Meinlschmidt G., Hellhammer D.H., Heim C. The low-dose dexamethasone suppression test in fibromyalgia. J. Psychosom. Res. 2007, 62:85-91.
67. Wingenfeld K., Heim C., Schmidt I., Wagner D., Meinlschmidt G., Hellhammer D.H. HPA axis reactivity and lymphocyte glucocorticoid sensitivity in fibromyalgia syndrome and chronic pelvic pain. Psychosom. Med. 2008, 70:65-72.
68. Wolfe F. Fibromyalgia: the clinical syndrome. Rheum Dis. Clin. North Am. 1989, 15:1-18.
69. Wolfe F., Smythe H.A., Yunus M.B., et al. The American college of rheumatology 1990 criteria for the classification of fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum 1990, 33:160-172.
70. Wolfe F., Ross K., Anderson J., Russell I.J., Herbert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995, 38:19-28.
71. Wurtman R.J., Axelrod J. Control of enzymatic synthesis of adrenaline in the adrenal medulla by adrenal cortical steroids. J. Biol. Chem. 1966, 241:2301-2305.
72. Wüst S., Wolf J., Hellhammer D.H., Federenko I., Schommer N., Kirschbaum C. The cortisol awakening response-normal values and confounds. Noise Health 2000, 2:79-88.
73. Yehuda R., Giller E.L., Southwick S.M., Lowy M.T., Mason J.M. Hypothalamic-pituitary-adrenal dysfunction in posttraumatic stress disorder. Biol. Psychiatry 1991, 30:1031-1048.
74. Yehuda R., Southwick S.M., Krystal J.H., Bremner D., Charney D.S., Mason J.W. Enhanced suppression of cortisol following dexamethasone administration in posttraumatic stress disorder. Am. J. Psychiatry 1993, 150:83-86.
75. Yehuda R. Sensitization of the hypothalamic-pituitary-adrenal axis in posttraumatic stress disorder. Ann. N.Y. Acad. Sci. 1997, 821:57-75.
76. Yehuda R., Golier J.A., Yang R.K., Tischler L. Enhanced sensitivity to glucocorticoids in peripheral mononuclear leukocytes in posttraumatic stress disorder. Biol. Psychiatry 2004, 55:1110-1116.